nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—Ovarian Infertility Genes—ESR2—osteoporosis	0.0103	0.0617	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—PTH1R—osteoporosis	0.00951	0.0568	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—CALCR—osteoporosis	0.00951	0.0568	CbGpPWpGaD
Goserelin—LHCGR—Ovarian Infertility Genes—CYP19A1—osteoporosis	0.00938	0.056	CbGpPWpGaD
Goserelin—LHCGR—Ovarian Infertility Genes—VDR—osteoporosis	0.0082	0.049	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—PTH—osteoporosis	0.005	0.0299	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—PTHLH—osteoporosis	0.00414	0.0247	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—CALCA—osteoporosis	0.00365	0.0218	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—MGLL—osteoporosis	0.00364	0.0218	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CALCR—osteoporosis	0.00345	0.0206	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTH1R—osteoporosis	0.00345	0.0206	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00326	0.0195	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00271	0.0162	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—ADCY5—osteoporosis	0.00259	0.0155	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00232	0.0139	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTH1R—osteoporosis	0.00231	0.0138	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CALCR—osteoporosis	0.00231	0.0138	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTH1R—osteoporosis	0.00195	0.0117	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CALCR—osteoporosis	0.00195	0.0117	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—POMC—osteoporosis	0.00191	0.0114	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTH—osteoporosis	0.00181	0.0108	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CALCR—osteoporosis	0.00177	0.0106	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTH1R—osteoporosis	0.00177	0.0106	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CNR2—osteoporosis	0.00177	0.0106	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—WNT1—osteoporosis	0.00166	0.00993	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00155	0.00929	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—MGLL—osteoporosis	0.00155	0.00926	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTHLH—osteoporosis	0.0015	0.00898	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MGLL—osteoporosis	0.00141	0.00841	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CALCA—osteoporosis	0.00132	0.00791	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CALCR—osteoporosis	0.00131	0.00781	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PTH1R—osteoporosis	0.00131	0.00781	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTH—osteoporosis	0.00121	0.00726	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CALCR—osteoporosis	0.00119	0.00709	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTH1R—osteoporosis	0.00119	0.00709	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CNR2—osteoporosis	0.00118	0.00707	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SOST—osteoporosis	0.00116	0.00692	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—WNT1—osteoporosis	0.00111	0.00665	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTH1R—osteoporosis	0.00105	0.00626	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CALCR—osteoporosis	0.00105	0.00626	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—MGLL—osteoporosis	0.00104	0.0062	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTH—osteoporosis	0.00103	0.00613	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTHLH—osteoporosis	0.00101	0.00601	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CNR2—osteoporosis	0.000999	0.00597	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MGLL—osteoporosis	0.000943	0.00563	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTH—osteoporosis	0.000931	0.00556	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000909	0.00543	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CNR2—osteoporosis	0.000907	0.00542	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CALCA—osteoporosis	0.000886	0.00529	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—WNT1—osteoporosis	0.000853	0.0051	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTHLH—osteoporosis	0.00085	0.00508	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MGLL—osteoporosis	0.000832	0.00497	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LRP5—osteoporosis	0.000812	0.00485	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000802	0.00479	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LRP6—osteoporosis	0.000777	0.00464	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOST—osteoporosis	0.000775	0.00463	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTHLH—osteoporosis	0.000771	0.00461	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CALCA—osteoporosis	0.000748	0.00447	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CALCR—osteoporosis	0.000701	0.00419	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTH1R—osteoporosis	0.000701	0.00419	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—POMC—osteoporosis	0.000692	0.00414	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PTH—osteoporosis	0.000686	0.0041	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CALCA—osteoporosis	0.000679	0.00406	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR2—osteoporosis	0.000669	0.004	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TLN1—osteoporosis	0.000656	0.00392	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTH—osteoporosis	0.000623	0.00372	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000609	0.00364	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CNR2—osteoporosis	0.000607	0.00363	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—WNT1—osteoporosis	0.000571	0.00341	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PTHLH—osteoporosis	0.000569	0.0034	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—P4HB—osteoporosis	0.000565	0.00338	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MGLL—osteoporosis	0.000557	0.00333	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTH—osteoporosis	0.00055	0.00329	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LRP5—osteoporosis	0.000543	0.00325	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RAP1A—osteoporosis	0.000541	0.00323	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CNR2—osteoporosis	0.000536	0.0032	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADCY5—osteoporosis	0.000532	0.00318	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NFATC1—osteoporosis	0.000527	0.00315	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DKK1—osteoporosis	0.000523	0.00313	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LRP6—osteoporosis	0.00052	0.00311	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTHLH—osteoporosis	0.000516	0.00309	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—WNT1—osteoporosis	0.000504	0.00301	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CALCA—osteoporosis	0.000501	0.00299	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGA—osteoporosis	0.00049	0.00293	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ADCY5—osteoporosis	0.000483	0.00289	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—POMC—osteoporosis	0.000464	0.00277	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTHLH—osteoporosis	0.000456	0.00272	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BMP2—osteoporosis	0.000456	0.00272	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CALCA—osteoporosis	0.000455	0.00272	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGB—osteoporosis	0.000446	0.00266	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TLN1—osteoporosis	0.000439	0.00262	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PSMA5—osteoporosis	0.000431	0.00257	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PSMA2—osteoporosis	0.000431	0.00257	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CALCA—osteoporosis	0.000401	0.0024	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—POMC—osteoporosis	0.000391	0.00234	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—P4HB—osteoporosis	0.000378	0.00226	CbGpPWpGaD
Goserelin—Palpitations—Conjugated Estrogens—osteoporosis	0.000369	0.000443	CcSEcCtD
Goserelin—Insomnia—Risedronate—osteoporosis	0.000369	0.000443	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTH—osteoporosis	0.000368	0.0022	CbGpPWpGaD
Goserelin—Anxiety—Zoledronate—osteoporosis	0.000368	0.000442	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000367	0.000441	CcSEcCtD
Goserelin—Paraesthesia—Risedronate—osteoporosis	0.000366	0.00044	CcSEcCtD
Goserelin—Pruritus—Estropipate—osteoporosis	0.000365	0.000438	CcSEcCtD
Goserelin—Discomfort—Zoledronate—osteoporosis	0.000365	0.000438	CcSEcCtD
Goserelin—Asthenia—Alendronate—osteoporosis	0.000365	0.000438	CcSEcCtD
Goserelin—Hypersensitivity—Ibandronate—osteoporosis	0.000365	0.000438	CcSEcCtD
Goserelin—Cough—Conjugated Estrogens—osteoporosis	0.000365	0.000438	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—KL—osteoporosis	0.000364	0.00218	CbGpPWpGaD
Goserelin—Dyspnoea—Risedronate—osteoporosis	0.000364	0.000437	CcSEcCtD
Goserelin—Hypotension—Pamidronate—osteoporosis	0.000362	0.000435	CcSEcCtD
Goserelin—Convulsion—Conjugated Estrogens—osteoporosis	0.000362	0.000435	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RAP1A—osteoporosis	0.000362	0.00216	CbGpPWpGaD
Goserelin—Dry mouth—Zoledronate—osteoporosis	0.000361	0.000434	CcSEcCtD
Goserelin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000361	0.000433	CcSEcCtD
Goserelin—Pruritus—Alendronate—osteoporosis	0.00036	0.000432	CcSEcCtD
Goserelin—Dyspepsia—Risedronate—osteoporosis	0.000359	0.000431	CcSEcCtD
Goserelin—Eye disorder—Estradiol—osteoporosis	0.000359	0.000431	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CNR2—osteoporosis	0.000359	0.00214	CbGpPWpGaD
Goserelin—Constipation—Ethinyl Estradiol—osteoporosis	0.000358	0.00043	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000357	0.00213	CbGpPWpGaD
Goserelin—Confusional state—Zoledronate—osteoporosis	0.000357	0.000429	CcSEcCtD
Goserelin—Hypersensitivity—Calcitriol—osteoporosis	0.000357	0.000429	CcSEcCtD
Goserelin—Cardiac disorder—Estradiol—osteoporosis	0.000356	0.000428	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ADCY5—osteoporosis	0.000356	0.00213	CbGpPWpGaD
Goserelin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000356	0.000427	CcSEcCtD
Goserelin—Myalgia—Conjugated Estrogens—osteoporosis	0.000356	0.000427	CcSEcCtD
Goserelin—Chest pain—Conjugated Estrogens—osteoporosis	0.000356	0.000427	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—POMC—osteoporosis	0.000355	0.00212	CbGpPWpGaD
Goserelin—Asthenia—Ibandronate—osteoporosis	0.000355	0.000426	CcSEcCtD
Goserelin—Anxiety—Conjugated Estrogens—osteoporosis	0.000354	0.000426	CcSEcCtD
Goserelin—Nausea—Etidronic acid—osteoporosis	0.000354	0.000426	CcSEcCtD
Goserelin—Oedema—Zoledronate—osteoporosis	0.000354	0.000425	CcSEcCtD
Goserelin—Anaphylactic shock—Zoledronate—osteoporosis	0.000354	0.000425	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000353	0.000424	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000353	0.000424	CcSEcCtD
Goserelin—Diarrhoea—Estropipate—osteoporosis	0.000353	0.000424	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NFATC1—osteoporosis	0.000353	0.00211	CbGpPWpGaD
Goserelin—Infection—Zoledronate—osteoporosis	0.000352	0.000423	CcSEcCtD
Goserelin—Fatigue—Risedronate—osteoporosis	0.000352	0.000422	CcSEcCtD
Goserelin—Insomnia—Pamidronate—osteoporosis	0.000351	0.000421	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—DKK1—osteoporosis	0.00035	0.00209	CbGpPWpGaD
Goserelin—Pruritus—Ibandronate—osteoporosis	0.00035	0.00042	CcSEcCtD
Goserelin—Pain—Risedronate—osteoporosis	0.000349	0.000419	CcSEcCtD
Goserelin—Constipation—Risedronate—osteoporosis	0.000349	0.000419	CcSEcCtD
Goserelin—Angiopathy—Estradiol—osteoporosis	0.000348	0.000419	CcSEcCtD
Goserelin—Shock—Zoledronate—osteoporosis	0.000348	0.000418	CcSEcCtD
Goserelin—Paraesthesia—Pamidronate—osteoporosis	0.000348	0.000418	CcSEcCtD
Goserelin—Diarrhoea—Alendronate—osteoporosis	0.000348	0.000418	CcSEcCtD
Goserelin—Asthenia—Calcitriol—osteoporosis	0.000348	0.000417	CcSEcCtD
Goserelin—Nervous system disorder—Zoledronate—osteoporosis	0.000347	0.000417	CcSEcCtD
Goserelin—Immune system disorder—Estradiol—osteoporosis	0.000347	0.000417	CcSEcCtD
Goserelin—Thrombocytopenia—Zoledronate—osteoporosis	0.000347	0.000416	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL6R—osteoporosis	0.000347	0.00207	CbGpPWpGaD
Goserelin—Dyspnoea—Pamidronate—osteoporosis	0.000346	0.000415	CcSEcCtD
Goserelin—Tachycardia—Zoledronate—osteoporosis	0.000346	0.000415	CcSEcCtD
Goserelin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000345	0.000414	CcSEcCtD
Goserelin—Chills—Estradiol—osteoporosis	0.000345	0.000414	CcSEcCtD
Goserelin—Somnolence—Pamidronate—osteoporosis	0.000345	0.000414	CcSEcCtD
Goserelin—Skin disorder—Zoledronate—osteoporosis	0.000344	0.000413	CcSEcCtD
Goserelin—Pruritus—Calcitriol—osteoporosis	0.000343	0.000412	CcSEcCtD
Goserelin—Hyperhidrosis—Zoledronate—osteoporosis	0.000342	0.000411	CcSEcCtD
Goserelin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000342	0.000411	CcSEcCtD
Goserelin—Diarrhoea—Raloxifene—osteoporosis	0.000342	0.000411	CcSEcCtD
Goserelin—Dyspepsia—Pamidronate—osteoporosis	0.000341	0.00041	CcSEcCtD
Goserelin—Dizziness—Estropipate—osteoporosis	0.000341	0.00041	CcSEcCtD
Goserelin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000341	0.00041	CcSEcCtD
Goserelin—Oedema—Conjugated Estrogens—osteoporosis	0.000341	0.00041	CcSEcCtD
Goserelin—Alopecia—Estradiol—osteoporosis	0.000339	0.000408	CcSEcCtD
Goserelin—Infection—Conjugated Estrogens—osteoporosis	0.000339	0.000407	CcSEcCtD
Goserelin—Diarrhoea—Ibandronate—osteoporosis	0.000339	0.000407	CcSEcCtD
Goserelin—Anorexia—Zoledronate—osteoporosis	0.000338	0.000405	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—WNT1—osteoporosis	0.000337	0.00202	CbGpPWpGaD
Goserelin—Decreased appetite—Pamidronate—osteoporosis	0.000337	0.000405	CcSEcCtD
Goserelin—Mental disorder—Estradiol—osteoporosis	0.000337	0.000404	CcSEcCtD
Goserelin—Dizziness—Alendronate—osteoporosis	0.000336	0.000404	CcSEcCtD
Goserelin—Shock—Conjugated Estrogens—osteoporosis	0.000335	0.000403	CcSEcCtD
Goserelin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000334	0.000402	CcSEcCtD
Goserelin—Erythema—Estradiol—osteoporosis	0.000334	0.000402	CcSEcCtD
Goserelin—Malnutrition—Estradiol—osteoporosis	0.000334	0.000402	CcSEcCtD
Goserelin—Fatigue—Pamidronate—osteoporosis	0.000334	0.000401	CcSEcCtD
Goserelin—Gastrointestinal pain—Risedronate—osteoporosis	0.000333	0.000401	CcSEcCtD
Goserelin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000333	0.0004	CcSEcCtD
Goserelin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000332	0.000399	CcSEcCtD
Goserelin—Pain—Pamidronate—osteoporosis	0.000332	0.000398	CcSEcCtD
Goserelin—Constipation—Pamidronate—osteoporosis	0.000332	0.000398	CcSEcCtD
Goserelin—Diarrhoea—Calcitriol—osteoporosis	0.000331	0.000398	CcSEcCtD
Goserelin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000331	0.000398	CcSEcCtD
Goserelin—Hypotension—Zoledronate—osteoporosis	0.000331	0.000397	CcSEcCtD
Goserelin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000331	0.000397	CcSEcCtD
Goserelin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000331	0.000397	CcSEcCtD
Goserelin—Dizziness—Raloxifene—osteoporosis	0.000331	0.000397	CcSEcCtD
Goserelin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00033	0.000396	CcSEcCtD
Goserelin—Flatulence—Estradiol—osteoporosis	0.000329	0.000396	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FGA—osteoporosis	0.000328	0.00196	CbGpPWpGaD
Goserelin—Tension—Estradiol—osteoporosis	0.000328	0.000394	CcSEcCtD
Goserelin—Vomiting—Estropipate—osteoporosis	0.000328	0.000394	CcSEcCtD
Goserelin—Dizziness—Ibandronate—osteoporosis	0.000327	0.000393	CcSEcCtD
Goserelin—Rash—Estropipate—osteoporosis	0.000325	0.000391	CcSEcCtD
Goserelin—Dermatitis—Estropipate—osteoporosis	0.000325	0.00039	CcSEcCtD
Goserelin—Anorexia—Conjugated Estrogens—osteoporosis	0.000325	0.00039	CcSEcCtD
Goserelin—Nervousness—Estradiol—osteoporosis	0.000325	0.00039	CcSEcCtD
Goserelin—Urticaria—Risedronate—osteoporosis	0.000324	0.000389	CcSEcCtD
Goserelin—Back pain—Estradiol—osteoporosis	0.000323	0.000388	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADCY5—osteoporosis	0.000323	0.00193	CbGpPWpGaD
Goserelin—Headache—Estropipate—osteoporosis	0.000323	0.000388	CcSEcCtD
Goserelin—Vomiting—Alendronate—osteoporosis	0.000323	0.000388	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000323	0.000387	CcSEcCtD
Goserelin—Abdominal pain—Risedronate—osteoporosis	0.000322	0.000387	CcSEcCtD
Goserelin—Body temperature increased—Risedronate—osteoporosis	0.000322	0.000387	CcSEcCtD
Goserelin—Muscle spasms—Estradiol—osteoporosis	0.000321	0.000386	CcSEcCtD
Goserelin—Rash—Alendronate—osteoporosis	0.00032	0.000385	CcSEcCtD
Goserelin—Insomnia—Zoledronate—osteoporosis	0.00032	0.000385	CcSEcCtD
Goserelin—Dermatitis—Alendronate—osteoporosis	0.00032	0.000385	CcSEcCtD
Goserelin—Feeling abnormal—Pamidronate—osteoporosis	0.000319	0.000384	CcSEcCtD
Goserelin—Hypotension—Conjugated Estrogens—osteoporosis	0.000319	0.000383	CcSEcCtD
Goserelin—Headache—Alendronate—osteoporosis	0.000318	0.000382	CcSEcCtD
Goserelin—Paraesthesia—Zoledronate—osteoporosis	0.000318	0.000382	CcSEcCtD
Goserelin—Vomiting—Raloxifene—osteoporosis	0.000318	0.000382	CcSEcCtD
Goserelin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000317	0.000381	CcSEcCtD
Goserelin—Dyspnoea—Zoledronate—osteoporosis	0.000316	0.000379	CcSEcCtD
Goserelin—Rash—Raloxifene—osteoporosis	0.000315	0.000379	CcSEcCtD
Goserelin—Dermatitis—Raloxifene—osteoporosis	0.000315	0.000378	CcSEcCtD
Goserelin—Somnolence—Zoledronate—osteoporosis	0.000315	0.000378	CcSEcCtD
Goserelin—Vomiting—Ibandronate—osteoporosis	0.000315	0.000378	CcSEcCtD
Goserelin—Headache—Raloxifene—osteoporosis	0.000313	0.000376	CcSEcCtD
Goserelin—Rash—Ibandronate—osteoporosis	0.000312	0.000375	CcSEcCtD
Goserelin—Dermatitis—Ibandronate—osteoporosis	0.000312	0.000374	CcSEcCtD
Goserelin—Dyspepsia—Zoledronate—osteoporosis	0.000312	0.000374	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000311	0.000373	CcSEcCtD
Goserelin—Ill-defined disorder—Estradiol—osteoporosis	0.00031	0.000373	CcSEcCtD
Goserelin—Headache—Ibandronate—osteoporosis	0.00031	0.000372	CcSEcCtD
Goserelin—Insomnia—Conjugated Estrogens—osteoporosis	0.000308	0.00037	CcSEcCtD
Goserelin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000308	0.00037	CcSEcCtD
Goserelin—Vomiting—Calcitriol—osteoporosis	0.000308	0.00037	CcSEcCtD
Goserelin—Decreased appetite—Zoledronate—osteoporosis	0.000308	0.00037	CcSEcCtD
Goserelin—Nausea—Estropipate—osteoporosis	0.000307	0.000368	CcSEcCtD
Goserelin—Abdominal pain—Pamidronate—osteoporosis	0.000306	0.000368	CcSEcCtD
Goserelin—Body temperature increased—Pamidronate—osteoporosis	0.000306	0.000368	CcSEcCtD
Goserelin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000306	0.000368	CcSEcCtD
Goserelin—Rash—Calcitriol—osteoporosis	0.000305	0.000367	CcSEcCtD
Goserelin—Fatigue—Zoledronate—osteoporosis	0.000305	0.000367	CcSEcCtD
Goserelin—Dermatitis—Calcitriol—osteoporosis	0.000305	0.000366	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTHLH—osteoporosis	0.000305	0.00182	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BMP2—osteoporosis	0.000305	0.00182	CbGpPWpGaD
Goserelin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000304	0.000365	CcSEcCtD
Goserelin—Headache—Calcitriol—osteoporosis	0.000303	0.000364	CcSEcCtD
Goserelin—Somnolence—Conjugated Estrogens—osteoporosis	0.000303	0.000364	CcSEcCtD
Goserelin—Constipation—Zoledronate—osteoporosis	0.000303	0.000364	CcSEcCtD
Goserelin—Pain—Zoledronate—osteoporosis	0.000303	0.000364	CcSEcCtD
Goserelin—Nausea—Alendronate—osteoporosis	0.000302	0.000363	CcSEcCtD
Goserelin—Malaise—Estradiol—osteoporosis	0.000302	0.000362	CcSEcCtD
Goserelin—Hypersensitivity—Risedronate—osteoporosis	0.0003	0.000361	CcSEcCtD
Goserelin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.0003	0.00036	CcSEcCtD
Goserelin—Asthenia—Ethinyl Estradiol—osteoporosis	0.0003	0.00036	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FGB—osteoporosis	0.000299	0.00178	CbGpPWpGaD
Goserelin—Nausea—Raloxifene—osteoporosis	0.000297	0.000357	CcSEcCtD
Goserelin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000296	0.000356	CcSEcCtD
Goserelin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000296	0.000355	CcSEcCtD
Goserelin—Palpitations—Estradiol—osteoporosis	0.000295	0.000355	CcSEcCtD
Goserelin—Fatigue—Conjugated Estrogens—osteoporosis	0.000294	0.000353	CcSEcCtD
Goserelin—Nausea—Ibandronate—osteoporosis	0.000294	0.000353	CcSEcCtD
Goserelin—Asthenia—Risedronate—osteoporosis	0.000293	0.000351	CcSEcCtD
Goserelin—Feeling abnormal—Zoledronate—osteoporosis	0.000292	0.00035	CcSEcCtD
Goserelin—Cough—Estradiol—osteoporosis	0.000292	0.00035	CcSEcCtD
Goserelin—Constipation—Conjugated Estrogens—osteoporosis	0.000292	0.00035	CcSEcCtD
Goserelin—Pain—Conjugated Estrogens—osteoporosis	0.000292	0.00035	CcSEcCtD
Goserelin—Gastrointestinal pain—Zoledronate—osteoporosis	0.00029	0.000348	CcSEcCtD
Goserelin—Hypertension—Estradiol—osteoporosis	0.000289	0.000347	CcSEcCtD
Goserelin—Pruritus—Risedronate—osteoporosis	0.000289	0.000347	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PSMA2—osteoporosis	0.000288	0.00172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PSMA5—osteoporosis	0.000288	0.00172	CbGpPWpGaD
Goserelin—Nausea—Calcitriol—osteoporosis	0.000288	0.000346	CcSEcCtD
Goserelin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000286	0.000344	CcSEcCtD
Goserelin—Hypersensitivity—Pamidronate—osteoporosis	0.000286	0.000343	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADCY5—osteoporosis	0.000285	0.00171	CbGpPWpGaD
Goserelin—Myalgia—Estradiol—osteoporosis	0.000285	0.000342	CcSEcCtD
Goserelin—Chest pain—Estradiol—osteoporosis	0.000285	0.000342	CcSEcCtD
Goserelin—Arthralgia—Estradiol—osteoporosis	0.000285	0.000342	CcSEcCtD
Goserelin—Anxiety—Estradiol—osteoporosis	0.000284	0.000341	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000283	0.00034	CcSEcCtD
Goserelin—Urticaria—Zoledronate—osteoporosis	0.000281	0.000338	CcSEcCtD
Goserelin—Discomfort—Estradiol—osteoporosis	0.000281	0.000338	CcSEcCtD
Goserelin—Abdominal pain—Zoledronate—osteoporosis	0.00028	0.000336	CcSEcCtD
Goserelin—Body temperature increased—Zoledronate—osteoporosis	0.00028	0.000336	CcSEcCtD
Goserelin—Diarrhoea—Risedronate—osteoporosis	0.000279	0.000335	CcSEcCtD
Goserelin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000279	0.000335	CcSEcCtD
Goserelin—Dry mouth—Estradiol—osteoporosis	0.000278	0.000334	CcSEcCtD
Goserelin—Asthenia—Pamidronate—osteoporosis	0.000278	0.000334	CcSEcCtD
Goserelin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000277	0.000332	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SPP1—osteoporosis	0.000276	0.00165	CbGpPWpGaD
Goserelin—Confusional state—Estradiol—osteoporosis	0.000275	0.00033	CcSEcCtD
Goserelin—Pruritus—Pamidronate—osteoporosis	0.000274	0.000329	CcSEcCtD
Goserelin—Anaphylactic shock—Estradiol—osteoporosis	0.000273	0.000328	CcSEcCtD
Goserelin—Oedema—Estradiol—osteoporosis	0.000273	0.000328	CcSEcCtD
Goserelin—Infection—Estradiol—osteoporosis	0.000271	0.000326	CcSEcCtD
Goserelin—Urticaria—Conjugated Estrogens—osteoporosis	0.000271	0.000325	CcSEcCtD
Goserelin—Dizziness—Risedronate—osteoporosis	0.00027	0.000324	CcSEcCtD
Goserelin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00027	0.000324	CcSEcCtD
Goserelin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00027	0.000324	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CALCA—osteoporosis	0.000269	0.0016	CbGpPWpGaD
Goserelin—Shock—Estradiol—osteoporosis	0.000268	0.000322	CcSEcCtD
Goserelin—Nervous system disorder—Estradiol—osteoporosis	0.000268	0.000321	CcSEcCtD
Goserelin—Tachycardia—Estradiol—osteoporosis	0.000266	0.00032	CcSEcCtD
Goserelin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000266	0.000319	CcSEcCtD
Goserelin—Diarrhoea—Pamidronate—osteoporosis	0.000265	0.000319	CcSEcCtD
Goserelin—Skin disorder—Estradiol—osteoporosis	0.000265	0.000318	CcSEcCtD
Goserelin—Hyperhidrosis—Estradiol—osteoporosis	0.000264	0.000317	CcSEcCtD
Goserelin—Rash—Ethinyl Estradiol—osteoporosis	0.000264	0.000317	CcSEcCtD
Goserelin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000263	0.000316	CcSEcCtD
Goserelin—Headache—Ethinyl Estradiol—osteoporosis	0.000262	0.000315	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—POMC—osteoporosis	0.000262	0.00157	CbGpPWpGaD
Goserelin—Hypersensitivity—Zoledronate—osteoporosis	0.000261	0.000313	CcSEcCtD
Goserelin—Vomiting—Risedronate—osteoporosis	0.000259	0.000311	CcSEcCtD
Goserelin—Rash—Risedronate—osteoporosis	0.000257	0.000309	CcSEcCtD
Goserelin—Dermatitis—Risedronate—osteoporosis	0.000257	0.000309	CcSEcCtD
Goserelin—Dizziness—Pamidronate—osteoporosis	0.000256	0.000308	CcSEcCtD
Goserelin—Headache—Risedronate—osteoporosis	0.000255	0.000307	CcSEcCtD
Goserelin—Asthenia—Zoledronate—osteoporosis	0.000254	0.000305	CcSEcCtD
Goserelin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000251	0.000302	CcSEcCtD
Goserelin—Pruritus—Zoledronate—osteoporosis	0.000251	0.000301	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IRS2—osteoporosis	0.00025	0.00149	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000249	0.000299	CcSEcCtD
Goserelin—Nausea—Ethinyl Estradiol—osteoporosis	0.000248	0.000298	CcSEcCtD
Goserelin—Insomnia—Estradiol—osteoporosis	0.000247	0.000296	CcSEcCtD
Goserelin—Vomiting—Pamidronate—osteoporosis	0.000246	0.000296	CcSEcCtD
Goserelin—Paraesthesia—Estradiol—osteoporosis	0.000245	0.000294	CcSEcCtD
Goserelin—Asthenia—Conjugated Estrogens—osteoporosis	0.000245	0.000294	CcSEcCtD
Goserelin—Rash—Pamidronate—osteoporosis	0.000244	0.000294	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—LEP—osteoporosis	0.000244	0.00146	CbGpPWpGaD
Goserelin—Dermatitis—Pamidronate—osteoporosis	0.000244	0.000293	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—KL—osteoporosis	0.000244	0.00146	CbGpPWpGaD
Goserelin—Dyspnoea—Estradiol—osteoporosis	0.000243	0.000292	CcSEcCtD
Goserelin—Headache—Pamidronate—osteoporosis	0.000243	0.000292	CcSEcCtD
Goserelin—Somnolence—Estradiol—osteoporosis	0.000243	0.000291	CcSEcCtD
Goserelin—Diarrhoea—Zoledronate—osteoporosis	0.000242	0.000291	CcSEcCtD
Goserelin—Nausea—Risedronate—osteoporosis	0.000242	0.000291	CcSEcCtD
Goserelin—Pruritus—Conjugated Estrogens—osteoporosis	0.000241	0.00029	CcSEcCtD
Goserelin—Dyspepsia—Estradiol—osteoporosis	0.00024	0.000288	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—POMC—osteoporosis	0.000238	0.00142	CbGpPWpGaD
Goserelin—Decreased appetite—Estradiol—osteoporosis	0.000237	0.000285	CcSEcCtD
Goserelin—Fatigue—Estradiol—osteoporosis	0.000235	0.000283	CcSEcCtD
Goserelin—Dizziness—Zoledronate—osteoporosis	0.000234	0.000281	CcSEcCtD
Goserelin—Pain—Estradiol—osteoporosis	0.000233	0.00028	CcSEcCtD
Goserelin—Constipation—Estradiol—osteoporosis	0.000233	0.00028	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ESR1—osteoporosis	0.000233	0.00139	CbGpPWpGaD
Goserelin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000233	0.00028	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL6R—osteoporosis	0.000232	0.00139	CbGpPWpGaD
Goserelin—Nausea—Pamidronate—osteoporosis	0.00023	0.000277	CcSEcCtD
Goserelin—Dizziness—Conjugated Estrogens—osteoporosis	0.000225	0.000271	CcSEcCtD
Goserelin—Vomiting—Zoledronate—osteoporosis	0.000225	0.00027	CcSEcCtD
Goserelin—Feeling abnormal—Estradiol—osteoporosis	0.000225	0.00027	CcSEcCtD
Goserelin—Rash—Zoledronate—osteoporosis	0.000223	0.000268	CcSEcCtD
Goserelin—Gastrointestinal pain—Estradiol—osteoporosis	0.000223	0.000268	CcSEcCtD
Goserelin—Dermatitis—Zoledronate—osteoporosis	0.000223	0.000268	CcSEcCtD
Goserelin—Headache—Zoledronate—osteoporosis	0.000222	0.000266	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IRS1—osteoporosis	0.000218	0.0013	CbGpPWpGaD
Goserelin—Vomiting—Conjugated Estrogens—osteoporosis	0.000217	0.00026	CcSEcCtD
Goserelin—Urticaria—Estradiol—osteoporosis	0.000217	0.00026	CcSEcCtD
Goserelin—Body temperature increased—Estradiol—osteoporosis	0.000216	0.000259	CcSEcCtD
Goserelin—Abdominal pain—Estradiol—osteoporosis	0.000216	0.000259	CcSEcCtD
Goserelin—Rash—Conjugated Estrogens—osteoporosis	0.000215	0.000258	CcSEcCtD
Goserelin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000215	0.000258	CcSEcCtD
Goserelin—Headache—Conjugated Estrogens—osteoporosis	0.000214	0.000257	CcSEcCtD
Goserelin—Nausea—Zoledronate—osteoporosis	0.00021	0.000253	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—POMC—osteoporosis	0.00021	0.00125	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6R—osteoporosis	0.000205	0.00122	CbGpPWpGaD
Goserelin—Nausea—Conjugated Estrogens—osteoporosis	0.000203	0.000243	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IGF1—osteoporosis	0.000202	0.00121	CbGpPWpGaD
Goserelin—Hypersensitivity—Estradiol—osteoporosis	0.000201	0.000241	CcSEcCtD
Goserelin—Asthenia—Estradiol—osteoporosis	0.000196	0.000235	CcSEcCtD
Goserelin—Pruritus—Estradiol—osteoporosis	0.000193	0.000232	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADCY5—osteoporosis	0.000191	0.00114	CbGpPWpGaD
Goserelin—Diarrhoea—Estradiol—osteoporosis	0.000187	0.000224	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SPP1—osteoporosis	0.000185	0.0011	CbGpPWpGaD
Goserelin—Dizziness—Estradiol—osteoporosis	0.00018	0.000217	CcSEcCtD
Goserelin—Vomiting—Estradiol—osteoporosis	0.000174	0.000208	CcSEcCtD
Goserelin—Rash—Estradiol—osteoporosis	0.000172	0.000207	CcSEcCtD
Goserelin—Dermatitis—Estradiol—osteoporosis	0.000172	0.000206	CcSEcCtD
Goserelin—Headache—Estradiol—osteoporosis	0.000171	0.000205	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—IRS2—osteoporosis	0.000167	0.000999	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—osteoporosis	0.000164	0.000977	CbGpPWpGaD
Goserelin—Nausea—Estradiol—osteoporosis	0.000162	0.000195	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ESR1—osteoporosis	0.000156	0.000933	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—osteoporosis	0.000154	0.000923	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS1—osteoporosis	0.000146	0.000872	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—POMC—osteoporosis	0.000141	0.00084	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6R—osteoporosis	0.000137	0.000819	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—osteoporosis	0.000135	0.000808	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—osteoporosis	0.000121	0.000725	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—osteoporosis	0.000121	0.000723	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—osteoporosis	0.000103	0.000618	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—osteoporosis	9.12e-05	0.000545	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—osteoporosis	8.12e-05	0.000485	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—osteoporosis	8.1e-05	0.000484	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—osteoporosis	6.11e-05	0.000365	CbGpPWpGaD
